
TY  - JOUR
AU  - VAN STRIJEN, M. J. L.
AU  - BLOEM, J. L.
AU  - DE MONYÃ‰, W.
AU  - KIEFT, G. J.
AU  - PATTYNAMA, P. M. T.
AU  - VAN DEN BERG-HUIJSMANS, A.
AU  - HUISMAN, M. V.
AU  - ON BEHALF OF THE ANTELOPE-STUDY GROUP
TI  - Helical computed tomography and alternative diagnosis in patients with excluded pulmonary embolism
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - 11
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.01596.x
DO  - doi:10.1111/j.1538-7836.2005.01596.x
SP  - 2449
EP  - 2456
KW  - alternative diagnosis
KW  - comparative studies
KW  - computed tomography
KW  - pulmonary embolism
PY  - 2005
AB  - Summary.? Objective:?A clinical diagnosis of pulmonary embolism (PE) is confirmed objectively in 20?30% of patients. Helical computed tomography (CT) can allow an alternative diagnosis to be made. The frequency and validity of alternative diagnoses on helical CT in consecutive patients presenting with clinically suspected PE was assessed. Patients and methods:?In all 512 prospectively analyzed patients helical CT scan was performed, and apart from presence or absence of PE, pathologic changes in lung parenchyma, mediastinum, cardiovascular system, pleura and skeleton were recorded. When possible an alternative diagnosis was given and compared with the final diagnosis after 3?months follow-up. Results:?In 130 patients (25.4%) PE was excluded and an alternative diagnosis considered likely. In 123 of the 130 patients (94.6%) this diagnosis was unchanged at 3?months follow-up. The diagnoses included pneumonia (n?=?67), malignancy (n?=?22), pleural fluid (n?=?10), cardiac failure (n?=?10), COPD (n?=?6) and a variety of other causes (n?=?15). The diagnosis changed at follow-up in seven patients (5.4%). An initial diagnosis of pneumonia changed to malignancy in two patients and to pleuritis and cardiac failure in one patient each. In two other patients malignancy and chronic obstructive pulmonary disease (COPD) were ruled out and the diagnosis changed to pneumonia. In one patient the final diagnosis remained unknown after an initial suspicion of malignancy. Conclusion:?In clinically suspected PE helical CT allows a reliable alternative diagnosis to be made in 25.4% of patients. This feature is an unique advantage in comparison with other diagnostic tests and supports the decision of taking helical CT as first line test in suspected PE.
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - British Journal of Haematology
VL  - 129
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2005.05435.x
DO  - doi:10.1111/j.1365-2141.2005.05435.x
SP  - 1
EP  - 83
PY  - 2005
ER  - 

TY  - JOUR
TI  - Oral abstracts (in program order)
JO  - Emergency Medicine Australasia
VL  - 20
IS  - s1
SN  - 1742-6731
UR  - https://doi.org/10.1111/j.1742-6723.2008.01059.x
DO  - doi:10.1111/j.1742-6723.2008.01059.x
SP  - A1
EP  - A25
PY  - 2008
ER  - 

TY  - JOUR
TI  - RESEARCH POSTER ABSTRACTS
JO  - Value in Health
VL  - 13
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2010.00722_2.x
DO  - doi:10.1111/j.1524-4733.2010.00722_2.x
SP  - A13
EP  - A219
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 14
IS  - s1
SN  - 1365-182X
UR  - https://doi.org/10.1111/j.1477-2574.2012.00437.x
DO  - doi:10.1111/j.1477-2574.2012.00437.x
SP  - 1
EP  - 91
PY  - 2012
ER  - 

TY  - JOUR
TI  - Podium Presentation Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 115
IS  - S4
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.13072
DO  - doi:10.1111/bju.13072
SP  - 1
EP  - 37
PY  - 2015
ER  - 

TY  - JOUR
TI  - ACCP Virtual Poster Symposium
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 37
IS  - 6
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.1964
DO  - doi:10.1002/phar.1964
SP  - e38
EP  - e70
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 74
IS  - S3
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.14740
DO  - doi:10.1111/anae.14740
SP  - 10
EP  - 95
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
JA  - HPB
VL  - 15
IS  - S1
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12048
DO  - doi:10.1111/hpb.12048
SP  - 1
EP  - 87
PY  - 2013
ER  - 

C7  - pp. xi-lvi
TI  - Index
SN  - 9780470683934
UR  - https://doi.org/10.1002/9781119952930.index
DO  - doi:10.1002/9781119952930.index
SP  - xi-lvi
PY  - 2013
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF SUBMISSIONS ACCEPTED FOR PRESENTATIOIN
JO  - Journal of General Internal Medicine
VL  - 20
IS  - S1
SN  - 9780470683934
UR  - https://doi.org/10.1111/j.1525-1497.2005.020S1.x
DO  - doi:10.1111/j.1525-1497.2005.020S1.x
SP  - 25
EP  - 279
PY  - 2005
ER  - 

TY  - JOUR
AU  - Mohammed, Ilyas
AU  - Syed, Wajihuddin
AU  - Kowey, Peter R.
TI  - Oral Anticoagulants to Reduce the Risk of Stroke in Atrial Fibrillation: How Should a Clinician Choose?
JO  - Clinical Cardiology
JA  - Clin Cardiol
VL  - 36
IS  - 11
SN  - 9780470683934
UR  - https://doi.org/10.1002/clc.22173
DO  - doi:10.1002/clc.22173
SP  - 663
EP  - 670
PY  - 2013
AB  - Abstract Atrial fibrillation (AF), a common arrhythmia that occurs with increasing frequency in the aging population, is associated with increased mortality and morbidity. To ensure that patients receive adequate anticoagulant prophylaxis, clinical guidelines for anticoagulation advocate use of validated scoring systems to stratify patients by cardiovascular risk and predict the individual patient's risk of adverse effects of therapy. Recently approved oral anticoagulants?a direct thrombin inhibitor and the factor Xa inhibitors?may offer advantages over the 50-year standard, warfarin, for efficacy, safety, and ease of administration. Clinical trial experience with the newly approved agents and others, yet to be approved, will define their relative value in reducing the risk of thromboembolism associated with AF. This article discusses issues that may help clinicians choose among these newer agents and individualize treatment appropriately.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Anaesthesia
VL  - 67
IS  - s1
SN  - 9780470683934
UR  - https://doi.org/10.1111/j.1365-2044.2011.07058.x
DO  - doi:10.1111/j.1365-2044.2011.07058.x
SP  - 6
EP  - 46
PY  - 2012
ER  - 

TY  - JOUR
TI  - Chronic Diseases E/CM
JO  - Journal of General Internal Medicine
VL  - 18
IS  - s1
SN  - 9780470683934
UR  - https://doi.org/10.1046/j.1525-1497.18.s1.6.x
DO  - doi:10.1046/j.1525-1497.18.s1.6.x
SP  - 140
EP  - 162
PY  - 2003
ER  - 

TY  - JOUR
TI  - AUGIS abstracts 2018
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 105
IS  - S6
SN  - 9780470683934
UR  - https://doi.org/10.1002/bjs.11039
DO  - doi:10.1002/bjs.11039
SP  - 5
EP  - 60
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of Paediatrics and Child Health
VL  - 43
IS  - s1
SN  - 9780470683934
UR  - https://doi.org/10.1111/j.1440-1754.2007.01099.x
DO  - doi:10.1111/j.1440-1754.2007.01099.x
SP  - A102
EP  - A143
PY  - 2007
ER  - 

TY  - JOUR
TI  - Short Papers
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 105
IS  - S5
SN  - 9780470683934
UR  - https://doi.org/10.1002/bjs.10970
DO  - doi:10.1002/bjs.10970
SP  - 12
EP  - 66
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2011 ACCP Annual Meeting
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 31
IS  - 10
SN  - 9780470683934
UR  - https://doi.org/10.1592/phco.31.10.311e
DO  - doi:10.1592/phco.31.10.311e
SP  - 311e
EP  - 453e
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 20
IS  - S1
SN  - 9780470683934
UR  - https://doi.org/10.1002/pds.2206
DO  - doi:10.1002/pds.2206
SP  - S1
EP  - S364
PY  - 2011
ER  - 

C7  - pp. 454-461
TI  - Index
SN  - 9780470654613
UR  - https://doi.org/10.1002/9781118274231.index
DO  - doi:10.1002/9781118274231.index
SP  - 454-461
PY  - 2011
ER  - 
